19-48968171-ACACT-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_002103.5(GYS1):c.*1113_*1116del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 453,768 control chromosomes in the GnomAD database, including 12 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0070 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 4 hom. )
Consequence
GYS1
NM_002103.5 3_prime_UTR
NM_002103.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.61
Genes affected
GYS1 (HGNC:4706): (glycogen synthase 1) The protein encoded by this gene catalyzes the addition of glucose monomers to the growing glycogen molecule through the formation of alpha-1,4-glycoside linkages. Mutations in this gene are associated with muscle glycogen storage disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 19-48968171-ACACT-A is Benign according to our data. Variant chr19-48968171-ACACT-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 329790.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00699 (1064/152260) while in subpopulation AFR AF= 0.0245 (1018/41556). AF 95% confidence interval is 0.0232. There are 8 homozygotes in gnomad4. There are 490 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GYS1 | NM_002103.5 | c.*1113_*1116del | 3_prime_UTR_variant | 16/16 | ENST00000323798.8 | ||
GYS1 | NM_001161587.2 | c.*1113_*1116del | 3_prime_UTR_variant | 15/15 | |||
GYS1 | NR_027763.2 | n.3342_3345del | non_coding_transcript_exon_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GYS1 | ENST00000323798.8 | c.*1113_*1116del | 3_prime_UTR_variant | 16/16 | 1 | NM_002103.5 | P1 | ||
GYS1 | ENST00000263276.6 | c.*1113_*1116del | 3_prime_UTR_variant | 15/15 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00701 AC: 1067AN: 152142Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1067
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00144 AC: 190AN: 132320Hom.: 1 AF XY: 0.00115 AC XY: 83AN XY: 72198
GnomAD3 exomes
AF:
AC:
190
AN:
132320
Hom.:
AF XY:
AC XY:
83
AN XY:
72198
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000905 AC: 273AN: 301508Hom.: 4 AF XY: 0.000634 AC XY: 109AN XY: 171790
GnomAD4 exome
AF:
AC:
273
AN:
301508
Hom.:
AF XY:
AC XY:
109
AN XY:
171790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00699 AC: 1064AN: 152260Hom.: 8 Cov.: 32 AF XY: 0.00658 AC XY: 490AN XY: 74440
GnomAD4 genome
AF:
AC:
1064
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
490
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Glycogen storage disease due to muscle and heart glycogen synthase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Hereditary hyperferritinemia with congenital cataracts Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Neuroferritinopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at